Assembly Biosciences Inc. announced the appointment of Jeanette M. Bjorkquist as its Principal Financial Officer on June 5, 2025. This appointment is a key change in the company's financial leadership structure.
The role of Principal Financial Officer is critical for overseeing the company's financial operations and strategy. This executive change is part of the ongoing management of the company's leadership team.
This appointment is expected to support Assembly Bio's continued efforts in advancing its clinical development programs and managing its financial resources effectively. The company remains focused on its mission to develop innovative therapeutics for serious viral diseases.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.